ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AKI Arthro Kinetics

0.10
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Arthro Kinetics Investors - AKI

Arthro Kinetics Investors - AKI

Share Name Share Symbol Market Stock Type
Arthro Kinetics AKI London Ordinary Share
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 0.10 01:00:00
Open Price Low Price High Price Close Price Previous Close
0.10 0.10
more quote information »

Top Investor Posts

Top Posts
Posted at 25/8/2006 10:47 by jonwig
The year end is 31 Dec, so they will be in a close period now - hence no director dealing allowed.
I'd expect the results for the half year sometime late next month or early October.

The two big deals yesterday were X trades, and may well have been rebalancing between MMs.
Posted at 19/5/2006 14:54 by jonwig
Investors Chronicle has a brief, positive, mention:

Arthro Kinetics

Product: Knee and spine regeneration products

Opportunity: Aim-newcomer Arthro Kinetics is the first German healthcare company to float on the junior market. It is developing implants to regenerate joints, using the patient's own cells, and focusing on the knee and spine. The surgery is less invasive and patients recover more quickly, saving healthcare costs, plus the theory is that it need only be done once. Conventional knee and spinal-disc replacements have to be renewed every few years, with more of the knee taken away. The knee cartilage-repair market was worth $500m in 2004, and the spine nucleus-replacement market is expected to be worth $2bn by 2010.

Management/partners: The company is already selling the knee product in Germany, and anticipates US approval in the second half of 2006. Chief executive Robert Guilleume comes from DePuy, owned by Johnson & Johnson, and has 20 years' experience of the hospital market.

Investment verdict: With enough cash to last until break-even (expected in 2007), the shares are good value.
Posted at 12/3/2004 11:25 by double6
MM 10k buy at 10.30 - buys since then - is there pressure on MM's or are they just trying to attract the investors ????
Posted at 10/3/2004 12:34 by responsible lad
did not know the investors chronicle covered this one. I should of bought it, damn. I often read it most weekends. Anyway there was a 10K sell at 28.25p just reported.
Posted at 10/3/2004 12:29 by seagreen
Look I will be honest this was tipped in Investors chronicle as a potential interesting vehicle and I was in a bullish mode as I had had a good friday and in a hurry I iresponsibly bought 10,000 of these on Monday without doing any research and told a mate and it kind of went from there. I then found out that it was a shell and sold again on tuesday for a small profit of £600....missing the major upside and maybe ther is something great going to come out of this, but if you are in this on a T10 or T5 and anyone is in profit my advice is take it and run. dyor. Particularly in this choppy market. If I am totally wrong and it becoems the next lastminutedot com I do appologise. I habve no long or short position open.
Posted at 17/1/2004 17:39 by simonevans
thread title a bit misleading for this co. Very high for a co. with net liabilities of £250-300k by now. Co. needs to get a deal away, but can't see this being at a very beneficial price for current investors - a technically insolvent position is not a very strong bargaining posn.
Posted at 05/11/2003 10:22 by mad4it
John

Not so! The chart is incorrect. The shares floated at 10p.

For all the those bullish on AKI I suggest you go back and check out the scandelous way this company was floated. The involvement of Hoodless Brennan caused a storm of protest at the time.

Stew

No problem. I think every thread needs balance to help the novice investor from falling victim to the rampers.

That's me done.
Posted at 04/11/2003 08:51 by stewjames
They have no business and net liabilities running at around a million quid. This rise is yet another of those absurd spikes caused by penny share investor speculation and totally without fundamental reason.
Posted at 09/4/2002 10:54 by johndee
Where are all the investors. Could this do what On-line did and go ballistic(like from 2.5 pence to £1 in a few days). It happened to On-line before the tech bubble began(went from 12.5 pence to £2.80 in four days). It is virtually the same company doing the same thing. It was in similar economic conditions to what we have now when investors were happy taking small profits.
Posted at 13/2/2002 23:08 by pinsticker
Hood is the MM holding the bid at 3.25p

Just imagine the spiel to the lucky investor:

"We've managed to get hold of a few AKI shares which we want to pass onto our best customers - this is an absolutely fantastic deal - the quote to SELL them is 3.25p and I'm offering them to you at an absolute steal of 3p. It's the bargain of the century!"

What a smelly endeavour.

Stew - in my view, the greatest conflict of interest lies with the management of ONL - they own AKI, and have now colluded twice IMO in the hoodwinking (sic) of the small investor - and they own ADVFN - positioned as the champion of the small investor.....

Your Recent History

Delayed Upgrade Clock